Neuromuscular diseases associated with HIV-1 infection

Muscle and Nerve

Volumn 40, Issue 6, 2009, Pages 1043-1053

  Robinson Papp, Jessica ^a   Simpson, David M ^a   Stucky, S ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

HIV; Myopathy; Neuromuscular; Neuropathy; Polyneuropathy

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; CAPSAICIN; CORTICOSTEROID; DULOXETINE; ETHER; GABAPENTIN; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; LAMOTRIGINE; LEVACECARNINE; LIDOCAINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PEPTIDE T; PREGABALIN; PYRIDOXINE; RECOMBINANT NERVE GROWTH FACTOR; THALIDOMIDE; UNINDEXED DRUG; VARICELLA ZOSTER VACCINE; ZIDOVUDINE;

ACUPUNCTURE; AUTONOMIC NEUROPATHY; BELL PALSY; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID ANALYSIS; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL TRIAL; CYTOMEGALOVIRUS; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISTAL SYMMETRIC POLYNEUROPATHY; DRUG MEGADOSE; ELECTROMYOGRAPHY; GUILLAIN BARRE SYNDROME; HERPES ZOSTER; HERPES ZOSTER OTICUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYPNOSIS; MONONEUROPATHY; MONONEUROPATHY MULTIPLEX; MYASTHENIA GRAVIS; MYOPATHY; NERVE BIOPSY; NERVE CONDUCTION; NERVE POTENTIAL; NEUROMUSCULAR DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; POLYMYOSITIS; POLYRADICULITIS; POSTHERPETIC NEURALGIA; PREVALENCE; PRIORITY JOURNAL; RADICULOPATHY; REVIEW; SJOEGREN SYNDROME; SYPHILIS; TUBERCULOSIS; VARICELLA ZOSTER VIRUS; WASTING SYNDROME;

HIV INFECTIONS; HIV-1; HUMANS; POLYNEUROPATHIES; QUALITY OF LIFE;

EID: 71549164080     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21465     Document Type: Review

References (104)

1. Morgello S, Estanislao L, Simpson D, et al. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV brain bank. Arch Neurol 2004;61:546-551. (Pubitemid 38923745)
2. Robinson-Papp J, Gonzalez-Duarte A, Simpson DM, Rivera-Mindt M, Morgello S. The roles of ethnicity and antiretrovirals in HIV-associated polyneuropathy: a pilot study. J Acq Immune Defic Syndr 2009;51:569-573.
3. Childs EA, Lyles RH, Selnes OA, et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 1999;52:607-613.
4. Simpson DM, Tagliati M. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J Acq Immune Defic Syndr Hum Retrovirol 1995;9:153-161.
5. Cherry CL, Skolasky RL, Lal L, et al. Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort. Neurology 2006;66:867-873. (Pubitemid 43739762)
6. Simpson DM, Kitch D, Evans SR, et al. HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology 2006;66:1679-1687. (Pubitemid 43964622)
7. Tagliati M, Grinnell J, Godbold J, Simpson DM. Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings. Arch Neurol 1999;56:84-89. (Pubitemid 29046913)
8. Parry GJ. Peripheral neuropathies associated with human immunodeficiency virus infection. Ann Neurol 1988;23(suppl):S49-53.
9. Chaunu MP, Ratinahirana H, Raphael M, et al. The spectrum of changes on 20 nerve biopsies in patients with HIV infection. Muscle Nerve 1989;12:452-459. (Pubitemid 19147504)
10. de la Monte SM, Gabuzda DH, Ho DD, et al. Peripheral neuropathy in the acquired immunodeficiency syndrome. Ann Neurol 1988;23:485-492. (Pubitemid 18127824)
11. Leger JM, Bouche P, Bolgert F, et al. The spectrum of polyneuropathies in patients infected with HIV. J Neurol Neurosurg Psychiatry 1989;52:1369-1374. (Pubitemid 20049109)
12. Mah V, Vartavarian LM, Akers MA, Vinters HV. Abnormalities of peripheral nerve in patients with human immunodeficiency virus infection. Ann Neurol 1988;24:713-717. (Pubitemid 19019024)
13. Winer JB, Bang B, Clarke JR, et al. A study of neuropathy in HIV infection. Q J Med 1992;83:473-488.
14. Zhou L, Kitch DW, Evans SR, et al. Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy. Neurology 2007;68:2113-2119. (Pubitemid 46912129)
15. Polydefkis M, Yiannoutsos CT, Cohen BA, et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 2002;58:115-119. (Pubitemid 34041947)
16. Pardo CA, McArthur JC, Griffin JW. HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J Peripher Nerv Syst 2001;6:21-27.
17. Hahn K, Robinson B, Anderson C, et al. Differential effects of HIV infected macrophages on dorsal root ganglia neurons and axons. Exp Neurol 2008;210:30-40.
18. van den Berg LH, Sadiq SA, Lederman S, Latov N. The gp120 glycoprotein of HIV-1 binds to sulfatide and to themyelin associated glycoprotein. J Neurosci Res 1992;33:513-518.
19. Apostolski S, McAlarney T, Quattrini A, et al. The gp120 glycoprotein of human immunodeficiency virus type 1 binds to sensory ganglion neurons. Ann Neurol 1993;34:855-863. (Pubitemid 23357901)
20. Keswani SC, Polley M, Pardo CA, Griffin JW, McArthur JC, Hoke A. Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol 2003;54:287-296. (Pubitemid 37072031)
21. Melli G, Keswani SC, Fischer A, Chen W, Hoke A. Spatially distinct and functionally independent mechanisms of axonal degeneration in a model of HIV-associated sensory neuropathy. Brain 2006;129:1330-1338.
22. Wallace VC, Blackbeard J, Pheby T, et al. Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy. Pain 2007;133:47-63. (Pubitemid 350138309)
23. Estanislao L, Geraci A, Di Rocco A, Simpson DS. HIV myelopathy, peripheral neuropathy and myopathy. In: Nath A, Berger J, editors. Clinical neurovirology. New York: Informa Healthcare; 2003. p 283.
24. Schifitto G, Yiannoutsos C, Simpson DM, et al. Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy. Neurology 2001;57:1313-1316. (Pubitemid 32947396)
25. Evans SR, Simpson DM, Kitch DW, et al. A randomized trial evaluating prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain. PLoS One 2007;2:e551.
26. Simpson DM, Dorfman D, Olney RK, et al. Peptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trial. Neurology 1996;47:1254-1259. (Pubitemid 26374896)
27. Valcour V, Yeh TM, Bartt R, et al. Acetyl-L-carnitine and nucleoside reverse transcriptase inhibitor associated neuropathy in HIV infection. HIV Med 2009;10:103-110.
28. Youle M, Osio M;ALCAR study group. A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection. HIV Med 2007;8:241-250.
29. Simpson DM, McArthur JC, Olney R, et al. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology 2003;60:1508-1514. (Pubitemid 36554814)
30. Hahn K, Arendt G, Braun JS, et al. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol 2004;251:1260-1266. (Pubitemid 39517931)
31. Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 2004;63:2104-2110. (Pubitemid 39636259)
32. Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005;6:253-260. (Pubitemid 40488803)
33. Simpson DM, Murphy TK, Durso-De Cruz E, Glue P, Whalen E. A randomized, double-blind, placebo-controlled, multicenter trial of pregabalin vs placebo in the treatment of neuropathic pain associated with HIV neuropathy. Program and abstracts of the XVII International AIDS Conference, August 2008; Mexico City, Mexico (Abstract THAB0301).
34. Shlay JC, Chaloner K, Max MB, et al. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn community programs for clinical research on AIDS. JAMA 1998;280:1590-1595. (Pubitemid 28520647)
35. Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005;116:109-118. (Pubitemid 40828506)
36. Raskin J, Pritchett YL, Wang F, et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005;6:346-356. (Pubitemid 41727332)
37. Simpson DM, Brown S, Tobias J, NGX-4010 C107 study group. Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology 2008;70:2305-2313.
38. Cergnul I, Ernst J, Blum S, Cadman J. Topical application of aspirin/diethyl ether in treatment of painful distal sensory polyneuropathy in HIV-positive individuals: a randomized, double-blind, crossover placebo-controlled study. Program abstracts of the 8th Conference on Retroviral Opportunistic Infection, February 2001, Chicago, IL (Abstract 601).
39. Estanislao L, Carter K, McArthur J, Olney R, Simpson D, et al. A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy. J Acq Immune Defic Syndr 2004;37:1584-1586. (Pubitemid 39658198)
40. Dorfman D, Montgomery G, George M, et al. Hypnosis for the treatment of HIV neuropathic pain. Pain 2008;9(suppl 2):59.
41. Ellis RJ, Toperoff W, Vaida F, et al. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology 2008;34:672-680.
42. Nicholson B, Passik SD. Management of chronic non-cancer pain in the primary care setting. South Med J 2007;100:1028-1036. (Pubitemid 47537888)
43. Wulff EA, Wang AK, Simpson DM. HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs 2000;59:1251-1260. (Pubitemid 30410143)
44. Cornblath DR, McArthur JC, Kennedy PG, Witte AS, Griffin JW. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol 1987;21:32-40. (Pubitemid 17004141)
45. van der Meche FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré study group. N Engl J Med 1992;326:1123-1129.
46. Serrano P, Hernandez N, Arroyo JA, de Llobet JM, Domingo P. Bilateral bell palsy and acute HIV type 1 infection: report of 2 cases and review. Clin Infect Dis 2007;44:e57-61.
47. Belec L, Gherardi R, Georges AJ, et al. Peripheral facial paralysis and HIV infection: report of four African cases and review of the literature. J Neurol 1989;236:411-414. (Pubitemid 19261894)
48. Keane JR. Bilateral seventh nerve palsy: analysis of 43 cases and review of the literature. Neurology 1994;44:1198-1202. (Pubitemid 24232214)
49. Robillard RB, Hilsinger RL Jr, Adour KK. Ramsay Hunt facial paralysis: clinical analyses of 185 patients. Otolaryngol Head Neck Surg 1986;95:292-297.
50. Uscategui T, Doree C, Chamberlain IJ, Burton MJ. Antiviral therapy for Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults. Cochrane Database Syst Rev 2008;4:CD006851. (Pubitemid 351805156)
51. Uscategui T, Doree C, Chamberlain IJ, Burton MJ. Corticosteroids as adjuvant to antiviral treatment in Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults. Cochrane Database Syst Rev 2008;3:CD006852. (Pubitemid 351805201)
52. Gnann JW Jr, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med 2002;347;5:340-346.
53. Sullivan FM, Swan IR, Donnan PT, et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med 2007;357:1598-1607. (Pubitemid 47598402)
54. Said G, Lacroix C, Chemouilli P, et al. Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol 1991;29:139-146.
55. Lange DJ, Britton CB, Younger DS, Hays AP. The neuromuscular manifestations of human immunodeficiency virus infections. Arch Neurol 1988;45:1084-1088. (Pubitemid 18239193)
56. Lipkin WI, Parry G, Kiprov D, Abrams D. Inflammatory neuropathy in homosexual men with lymphadenopathy. Neurology 1985;35:1479-1483. (Pubitemid 15242427)
57. So Y, Olney R. The natural history of mononeuritis multiplex and simplex in HIV infection. Neurology 1991;41(suppl 1):375.
58. Miller RG, Parry GJ, Pfaeffl W, Lang W, Lippert R, Kiprov D. The spectrum of peripheral neuropathy associated with ARC and AIDS. Muscle Nerve 1988;11:857-863. (Pubitemid 18192564)
59. Estanislao LB, Morgello S, Simpson DM. Peripheral neuropathies associated with hepatitis C co-infection: a review. AIDS 2005;19(suppl 3):S135-139. (Pubitemid 41682181)
60. Cohen JA, Laudenslager M. Autonomic nervous system involvement in patients with human immunodeficiency virus infection. Neurology 1989;39:1111-1112. (Pubitemid 19217486)
61. Freeman R, Roberts MS, Friedman LS, Broadbridge C. Autonomic function and human immunodeficiency virus infection. Neurology 1990;40:575-580. (Pubitemid 20139079)
62. Compostella C, Compostella L, D'Elia R. The symptoms of autonomic dysfunction in HIV-positive Africans. Clin Auton Res 2008;18:6-12.
63. Sakhuja A, Goyal A, Jaryal AK, et al. Heart rate variability and autonomic function tests in HIV positive individuals in India. Clin Auton Res 2007;17:193-196. (Pubitemid 47030217)
64. Lebech AM, Kristoffersen US, Mehlsen J, et al. Autonomic dysfunction in HIV patients on antiretroviral therapy: studies of heart rate variability. Clin Physiol Funct Imag 2007;27:363-367. (Pubitemid 47604420)
65. Mittal CM, Wig N, Mishra S, Deepak KK. Heart rate variability in human immunodeficiency virus-positive individuals. Int J Cardiol 2004;94:1-6. (Pubitemid 38314680)
66. Chittiprol S, Kumar AM, Satishchandra P, et al. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in south India. Psychoneuroendocrinology 2008;33:30-40.
67. Miller RG, Storey JR, Greco CM. Ganciclovir in the treatment of progressive AIDS-related polyradiculopathy. Neurology 1990;40:569-574.
68. Lanska MJ, Lanska DJ, Schmidley JW. Syphilitic polyradiculopathy in an HIV-positive man. Neurology 1988;38:1297-1301.
69. Leger JM, Henin D, Belec L, et al. Lymphoma-induced polyradiculopathy in AIDS: two cases. J Neurol 1992;239:132-134.
70. Bazan C III, Jackson C, Jinkins JR, Barohn RJ. Gadolinium-enhanced MRI in a case of cytomegalovirus polyradiculopathy. Neurology 1991;41:1522-1523.
71. Kim YS, Hollander H. Polyradiculopathy due to cytomegalovirus: report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clin Infect Dis 1993;17:32-37. (Pubitemid 23197561)
72. Miller RF, Fox JD, Thomas P, et al. Acute lumbosacral polyradiculopathy due to cytomegalovirus in advanced HIV disease: CSF findings in 17 patients. J Neurol Neurosurg Psychiatry 1996;61:456-460. (Pubitemid 26394901)
73. So YT, Olney RK. Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients. Ann Neurol 1994;35:53-58. (Pubitemid 24027606)
74. Vafai A, Berger M. Zoster in patients infected with HIV: a review. Am J Med Sci 2001;321:372-380. (Pubitemid 33753075)
75. Whitley RJ, Weiss H, Gnann JW Jr, et al. Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases collaborative antiviral study group. Ann Intern Med 1996;125:376-383.
76. Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994;330:896-900. (Pubitemid 24094969)
77. Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and post herpetic neuralgia. Mayo Clin Proc 2009;84:274-280.
78. Simpson DM, Bender AN. Human immunodeficiency virus-associated myopathy: analysis of 11 patients. Ann Neurol 1988;24:79-84. (Pubitemid 18171379)
79. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-347.
80. Illa I, Nath A, Dalakas M. Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis. Ann Neurol 1991;29:474-481.
81. Johnson RW, Williams FM, Kazi S, Dimachkie MM, Reveille JD. Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome. Arthritis Rheum 2003;49:172-178. (Pubitemid 36418274)
82. Sellier P, Monsuez JJ, Evans J, et al. Human immunodeficiency virus-associated polymyositis during immune restoration with combination antiretroviral therapy. Am J Med 2000;109:510-512. (Pubitemid 30782708)
83. Arnaudo E, Dalakas M, Shanske S, Moraes CT, DiMauro S, Schon EA. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 1991;337:508-510.
84. Cupler EJ, Danon MJ, Jay C, Hench K, Ropka M, Dalakas MC. Early features of zidovudine-associated myopathy: histopathological findings and clinical correlations. Acta Neuropathol 1995;90:1-6.
85. HIV Neuromuscular Syndrome Study Group. HIV-associated neuromuscular weakness syndrome. AIDS 2004;18:1403-1412.
86. Soriano V, Laguna F, Diaz F, et al. Pyomyositis in patients with HIV infection. AIDS 1993;7:1020-1021.
87. Gherardi R, Baudrimont M, Lionnet F, et al. Skeletal muscle toxoplasmosis in patients with acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol 1992;32:535-542.
88. O'Neill KM, Ormsby AH, Prayson RA. Cryptococcal myositis: a case report and review of the literature. Pathology 1998;30:316-317.
89. Wrzolek MA, Sher JH, Kozlowski PB, Rao C. Skeletal muscle pathology in AIDS: an autopsy study. Muscle Nerve 1990;13:508-515. (Pubitemid 20173580)
90. Miro O, Pedrol E, Cebrian M, et al. Skeletal muscle studies in patients with HIV-related wasting syndrome. J Neurol Sci 1997;150:153-159. (Pubitemid 27317695)
91. Chariot P, Ruet E, Authier FJ, Levy Y, Gherardi R. Acute rhabdomyolysis in patients infected by human immunodeficiency virus. Neurology 1994;44:1692-1696. (Pubitemid 24286649)
92. Gresh JP, Aquilar JL, Espinoza LR. Human immunodeficiency virus (HIV) infection-associated dermatomyositis. J Rheumatol 1989;16:1397-1398.
93. Feinberg DM, Spiro AJ, Weidenheim KM. Distinct light microscopic changes in human immunodeficiency virus-associated nemaline myopathy. Neurology 1998;50:529-531. (Pubitemid 28119808)
94. Dalakas MC, Rakocevic G, Shatunov A, Goldfarb L, Raju R, Salajegheh M. Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T cells. Ann Neurol 2007;61:466-475. (Pubitemid 46878774)
95. Basu D, Williams FM, Ahn CW, Reveille JD. Changing spectrum of the diffuse infiltrative lymphocytosis syndrome. Arthritis Rheum 2006;55:466-472. (Pubitemid 43887033)
96. Gherardi RK, Chretien F, Delfau-Larue MH, et al. Neuropathy in diffuse infiltrative lymphocytosis syndrome: an HIV neuropathy, not a lymphoma. Neurology 1998;50:1041-1044. (Pubitemid 28212835)
97. Henning F, Hewlett RH. Brachial amyotrophic diplegia (segmental proximal spinal muscular atrophy) associated with HIV infection. J Neurol Neurosurg Psychiatry 2008;79:1392-1394.
98. Almeida V, Mestre T, Carvalho MD. Pseudobulbar syndrome in two patients with human immunodeficiency virus infection. Amyotroph Lateral Scler 2009;6:1-3.
99. Verma A, Berger JR. Primary lateral sclerosis with HIV-1 infection. Neurology 2008;70:575-577. (Pubitemid 351653384)
100. Verma A, Berger JR. ALS syndrome in patients with HIV-1 infection. J Neurol Sci 2006;240:59-64. (Pubitemid 41814954)
101. Nath A, Kerman RH, Novak IS, Wolinsky JS. Immune studies in human immunodeficiency virus infection with myasthenia gravis: a case report. Neurology 1990;40:581-583. (Pubitemid 20139080)
102. Elder G, Dalakas M, Pezeshkpour G, Sever J. Ataxic neuropathy due to ganglioneuronitis after probable acute human immunodeficiency virus infection. Lancet 1986;2:1275-1276. (Pubitemid 17182858)
103. Torno M, Vollmer M, Beck CK. West Nile virus infection presenting as acute flaccid paralysis in an HIV-infected patient: a case report and review of the literature. Neurology 2007;68:E5-7. (Pubitemid 46263198)
104. Jamison SC, Michaels SR, Ratard R, Sweet JM, Deboisblanc BP. A 41-year-old HIV-positive man with acute onset of quadriplegia after West Nile virus infection. South Med J 2007;100:1051-1053. (Pubitemid 47537894)